Mynflu001
/ Mynvax
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
October 18, 2024
A study to test the safety of MYNFLU001 Influenza Vaccine in Healthy Adults
(ANZCTR)
- P1 | N=45 | Completed | Sponsor: Mynvax Pty. Ltd. | Active, not recruiting ➔ Completed
Trial completion • Infectious Disease • Influenza • Respiratory Diseases
May 03, 2024
A study to test the safety of MYNFLU001 Influenza Vaccine in Healthy Adults
(ANZCTR)
- P1 | N=45 | Active, not recruiting | Sponsor: Mynvax Pty. Ltd. | Recruiting ➔ Active, not recruiting
Enrollment closed • Infectious Disease • Influenza • Respiratory Diseases
April 05, 2024
A study to test the safety of MYNFLU001 Influenza Vaccine in Healthy Adults
(ANZCTR)
- P1 | N=45 | Recruiting | Sponsor: Mynvax Pty. Ltd. | Not yet recruiting ➔ Recruiting | Initiation date: Nov 2023
Enrollment open • Trial initiation date • Infectious Disease • Influenza • Respiratory Diseases
September 13, 2023
A study to test the safety of MYNFLU001 Influenza Vaccine in Healthy Adults
(ANZCTR)
- P1 | N=45 | Not yet recruiting | Sponsor: Mynvax Pty. Ltd.
New P1 trial • Infectious Disease • Influenza • Respiratory Diseases
1 to 4
Of
4
Go to page
1